Skip to main content
. 2018 Mar 12;32(4):387–398. doi: 10.1007/s40263-018-0498-4

Fig. 1.

Fig. 1

Pooled population used in this analysis arising from the EASE LID and EASE LID 3 trials. aThe pooled safety population included an additional two patients, both in EASE LID, who received placebo but did not provide a post-baseline UDysRS assessment. mITT modified intent-to-treat, UDysRS Unified Dyskinesia Rating Scale